Pubblicazioni

Environmental modifiable risk factors for multiple sclerosis. Report from the 2016 Ectrims focused workshop

2018 - MULTIPLE SCLEROSIS

Amato, Maria Pia; Derfuss, Tobias; Hemmer, Bernard; Liblau, Roland; Montalban, Xavier; Soelberg SÃ¸rensen, Per; Miller, David H; Alfredsson, Lars; Aloisi, Francesca; Amato, Maria Pia; Ascherio, Alberto; Baldin, Elisa; BjÃ¸rnevik, Kjetil; Comabella, Manuel; Correale, Jorge; Cortese, Marianna; Derfuss, Tobias; DâHooghe, Marie; Ghezzi, Angelo; Gold, Julian; Hellwig, Kerstin; Hemmer, Bernhard; Koch-Henricksen, Nils; Langer Gould, Annette; Liblau, Roland; Linker, Ralf; Lolli, Francesco; Lucas, Robyn; LÃ¼nemann, Jan; Magyari, Melinda; Massacesi, Luca; Miller, Ariel; Miller, David H; Montalban, Xavier; Monteyne, Philippe; Mowry, Ellen; MÃ¼nz, Christian; Nielsen, Nete M; Olsson, Tomas; Oreja-Guevara, Celia; Otero, Susana; Pugliatti, Maura; Reingold, Stephen; Riise, Trond; Robertson, Neil; Salvetti, Marco; Sidhom, Youssef; Smolders, Joost; Soelberg SÃ¸rensen, Per; Sollid, Ludvig; Steiner, Israel; Stenager, Egon; Sundstrom, Peter; Taylor, Bruce V; Tremlett, Helen; Trojano, Maria; Uccelli, Antonio; Waubant, Emmanuelle; Wekerle, Hartmut

The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis

2016 - MULTIPLE SCLEROSIS

PastÃ², Luisa; Portaccio, Emilio; Goretti, Benedetta; Ghezzi, Angelo; Lori, Silvia; Hakiki, Bahia; Giannini, Marta; Righini, Isabella; Razzolini, Lorenzo; Niccolai, Claudia; Moiola, Lucia; Falautano, Monica; Simone, Marta; Viterbo, Rosa Gemma; Patti, Francesco; Cilia, Sabina; Pozzilli, Carlo; Bianchi, Valentina; Roscio, Marco; Martinelli, Vittorio; Comi, Giancarlo; Trojano, Maria; Amato, Maria Pia

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

2016 - MULTIPLE SCLEROSIS

Macdonell, Richard; Nagels, Guy; Laplaud, David-Axel; Pozzilli, Carlo; De Jong, Brigit; Martins Da Silva, Ana; Nicholas, Richard; Lechner-Scott, Jeannette; Gaebler, Julia A.; Agarwal, Sonalee; Wang, Ping; Yeh, Michael; Hovenden, Maria; Soelberg SÃ¸rensen, Per

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)

2016 - MULTIPLE SCLEROSIS

Lanzillo, Roberta; Quarantelli, Mario; Pozzilli, Carlo; Trojano, Maria; Amato, Maria Pia; Marrosu, Maria G.; Francia, Ada; Florio, Ciro; Orefice, Giuseppe; Tedeschi, Gioacchino; Bellantonio, Paolo; Annunziata, Pasquale; Grimaldi, Luigi M.; Comerci, Marco; Brunetti, Arturo; Bonavita, Vincenzo; Alfano, Bruno; Marini, Stefano; Brescia Morra, Vincenzo

Pubblicazioni

Environmental modifiable risk factors for multiple sclerosis. Report from the 2016 Ectrims focused workshop

The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)